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In 1988, Ludwig et al proposed the term idiopathic adulthood ductopenia (IAD) for the condition of 
chronic cholestatic liver disease associated with loss of intrahepatic bile ducts of unknown etiology 
with clinical onset in adulthood (1). 
In recent years, several cases of idiopathic biliary ductopenia in adulthood have been described. 
This disease is severe in most cases and can progress to cirrhosis. For progressive IAD, orthotopic 
liver transplantation (OLT) has been the only successful treatment. There are only a few cases 
reported of OLT for IAD and no information is available about the prognosis of these patients in the 
long term after OLT. In the present report, we describe the long-term follow-up after OLT in one 
patient fulfilling IAD criteria. 
 
CASE REPORT 
 
A 44-year-old female patient was referred to our institution in 1992 for OLT. She was otherwise 
healthy until 1989, when she started to have progressive symptoms of fatigue, pruritus, jaundice, 
dark urine, and pallor of the stools. She had no history of neonatal jaundice or liver disease in 
infancy or blood transfusions. There was no familial history of cholestasis. 
The only relevant findings on physical examination were severe jaundice, moderate 
hepatomegaly, and splenomegaly. 
Laboratory studies revealed the following findings: hemoglobin, 11 g/dl; white blood count, 
6.1/pl; platelets, 199/pl; ALT, 133 IU/L; AST, 222 IU/L; GGT, IU/L; alkaline phosphatase, 2400 
IU/L; total bilirubin, 31.94 mg/dl; conjugated bilirubin, 22.59 mg/dl; albumin, 3.36 g/dl; 
prothrombin time, 84%; cholesterol, 858 mg/dl; and triglycerides, 189 mg/dl. Serum iron, transferrin 
saturation, ferritin, a-1-antitrypsin, and ceruloplasmin were normal. Serological tests for anti-smooth 
muscle, anti-neutrophil–cytoplasm, antinuclear, antimitochondrial, and anti-liver– kidney microsome 
antibodies, hepatitis B surface antigen, and hepatitis C virus serology were negative. Serological 
tests for infection by cytomegalovirus (CMV), Epstein–Barr virus (EBV), and Herpes virus were as 
follows: CMV IgM, negative; CMV IgG, 715 U/ml; EBV VCA, 1/160; EBV, EA, 1/40; and herpes 
virus, 2.06 U/ml. a-Fetoprotein was normal. Serological test for HIV antibodies was negative. 
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An ultrasound study demonstrated hepatomegaly. No evidence of cholelithiasis or biliary dilation 
was noted. The spleen measured 14.5 cm and there was no ascites. The portal blood flow was 
hepatopetal. An endoscopy retrograde cholangiopancreatography demonstrated completely normal 
extrahepatic bile ducts and minimal irregularities of the intrahepatic bile ducts in the left lobe. A 
colonoscopy revealed no evidence of inflammatory bowel disease. Two percutaneous liver biopsies 
performed at another hospital showed severe cholestasis. 
OLT was performed in February 1993. An end-to-end choledochocholedochostomy was performed 
over a T-tube. Immunosuppressive therapy was begun with cyclosporine, methylprednisolone, and 
azathioprine. The native liver weighed 2120 g and measured 19.5 x 24 x 10.2 cm. The specimen had 
smooth, green light outer surfaces. After the cut, the surface was green with white areas. The 
gallbladder measured 7.5 x 2.5 cm. Microscopically the liver showed cholestasis with bile plugs 
(Figure 1), fibrosis, and a reduction in the number of interlobar bile ducts (Figure 2). In 37 portal 
tracts, only two bile ducts were found. An orcein stain for copper-associated protein was negative. 
There were no granulomas or infiltration with inflammatory cells. In the described clinical setting, 
these pathological findings confirmed the diagnosis of IAD. 
One episode of acute cellular rejection occurred on day 5 after OLT, which was reversed with 
steroid bolus therapy. Following this episode, the patient’s clinical course was uneventful. From 
1993 to 2000 liver function tests have been obtained at our center each year and no abnormal liver 
function tests have been observed. Steroid therapy was discontinued by September 1998 and 
azathioprine by November 1998. At this time, the patient is on cyclosporine monotherapy. A 
follow-up percutaneous liver biopsy performed in 1998 showed mild nonspecific findings (mild 
lymphocytic infiltrate in all portal tracts and minimal centrilobular cholestasis). In four portal tracts, 
four bile ducts were observed (Figure 3). Liver function tests at the time of liver biopsy were as 
follows: AST, 16 IU/L; ALT, 18 IU/L; GGT, 22 IU/L; alkaline phosphatase, 138 IU/L; total bili-
rubin, 0.6 mg/dl; and conjugated bilirubin, 0.18 mg/dl. 
 
 
DISCUSSION 
 
Idiopathic adulthood ductopenia (IAD) is a term that describes a chronic cholestatic liver disease 
of unknown etiology which has its clinical onset in adulthood and is associated with loss of 
intrahepatic bile ducts. Clinical onset consists in jaundice, pruritus, and hemorrhage by portal 
hypertension, and elevated levels of alkaline phosphatase and hyperbilirubinemia are revealed in 
blood tests (2). 
Several groups have reported patients with idiopathic adulthood ductopenia. Of a total of 57 
patients described so far (3), few patients, including our case, are more than 40 years of age at the 
onset of the symptoms. 
 
In our case the clinicopathologic findings are quite similar to those described by other authors. 
The most prominent feature of the histological examination of the native liver was ductopenia, 
defined as the presence of identifiable bile duct in less than 50% of portal tracts. According to 
established criteria (3) our case can be classified as adulthood ductopenia. 
Although most cases are sporadic, familial cases have been described (4). The clinical course of 
IAD is variable. Frequently some patients have progressive cholestasis leading to biliary cirrhosis 
(5), while others have stable disease (6). Moreno et al. reported on 24 patients with an asymptomatic 
elevation in liver enzymes and ductopenia with an apparent nonprogressive course. The beneficial 
effect of treatment with ursodeoxycholic acid has been suggested (6, 7). When progression to liver 
failure occurs, OLT is indicated. Its evolution after OLT is unknown. 
IAD is considered a syndrome with several possible causes such as late-onset nonsyndromic 
paucity of intrahepatic bile ducts, small-duct primary sclerosing cholangitis, viral cholangitis, 
autoimmune hepatitis, and cholangitis (3), hence the possibility of recurrent disease after liver 
transplantation should be considered. In fact, recurrence of primary disease in patients undergoing 
liver transplantation due to chronic cholestatic conditions such as primary biliary cirrhosis (8), 
autoimmune hepatitis (9), and primary sclerosing cholangitis (10) is a widely reported event. 
The evolution after OLT is unknown. As far as we know, only seven patients have received OLT 
for IAD (1, 11–14). Only three of these patients have been reported to be alive and well 1 to 2 years 
after OLT (11, 13) and liver function tests are reported to be normal in only one case (11). 
In our case no clinical or biochemical indicating recurrent cholestasis have developed 7 years after 
transplantation. A liver biopsy performed 6 years after transplantation revealed only a mild 
inflammatory infiltrate and minimal centrolobular cholestasis. These findings may be considered 
nonspecific and are frequently found in liver grafts, with otherwise normal function several years 
after transplantation. In addition, all portal tracts showed the presence of a bile duct. 
In conclusion, this is the first report of the longterm evolution of IAD after OLT in one case in 
which no signs of disease recurrence have been noted 7 years after OLT. 
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Fig 1. Section of the explanted liver showing intense cholostasis with bile plug formation and rosetoid 
transformation of the hepatocytes. HE; original magnification, X450. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig 2. Portal tract without interlobular bile ducts. Immunohistochemical stain with cytokeratin 
(AE3–AE1) failed to show epithelial bile cells. Note the intense ductular transformation of the 
peripheral hepatocytes. AE3–AE1, DAB; original magnification, X200. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig 3. Four-year-posttransplant biopsy showing only mild nonspecific changes, scattered portal 
lymphocytes, and minimal hepatocyte cholestasis. 
 
 
 
